These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 8383104

  • 21. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
    Robbins MJ, Baskerville AJ, Sanghrajka M, Mumtaz G, Felmingham D, Ridgway GL, Grüneberg RN.
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
    [Abstract] [Full Text] [Related]

  • 22. In vitro evaluation of BAY Y3118, a new full-spectrum fluoroquinolone.
    Bremm KD, Petersen U, Metzger KG, Endermann R.
    Chemotherapy; 1992; 38(6):376-87. PubMed ID: 1288961
    [Abstract] [Full Text] [Related]

  • 23. Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.
    Harnett SJ, Fraise AP, Andrews JM, Jevons G, Brenwald NP, Wise R.
    J Antimicrob Chemother; 2004 May; 53(5):783-92. PubMed ID: 15056651
    [Abstract] [Full Text] [Related]

  • 24. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone.
    Qadri SM, Ueno Y, Burns JJ, Almodovar E, Rabea N.
    Chemotherapy; 1992 May; 38(2):99-106. PubMed ID: 1317282
    [Abstract] [Full Text] [Related]

  • 25. Comparative in vitro activity of sparfloxacin (AT 4140, RP 64206--SPFX) against 275 multiresistant clinical isolates.
    Giamarellou H, Voutsinas D, Xirouchaki E.
    J Chemother; 1992 Feb; 4(1):12-5. PubMed ID: 1328554
    [Abstract] [Full Text] [Related]

  • 26. The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent.
    Boswell FJ, Andrews JM, Ashby JP, Fogarty C, Brenwald NP, Wise R.
    J Antimicrob Chemother; 1998 Dec; 42(6):703-9. PubMed ID: 10052892
    [Abstract] [Full Text] [Related]

  • 27. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin.
    Fung-Tomc J, Minassian B, Kolek B, Washo T, Huczko E, Bonner D.
    J Antimicrob Chemother; 2000 Apr; 45(4):437-46. PubMed ID: 10747819
    [Abstract] [Full Text] [Related]

  • 28. Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.
    Sato K, Hoshino K, Tanaka M, Hayakawa I, Osada Y.
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1491-8. PubMed ID: 1324647
    [Abstract] [Full Text] [Related]

  • 29. Comparative activities of eight quinolones against members of the Bacteroides fragilis group.
    Borobio MV, Conejo M, Ramirez E, Suarez AI, Perea EJ.
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1442-5. PubMed ID: 8092852
    [Abstract] [Full Text] [Related]

  • 30. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA, Tayeb OS.
    Microbios; 1993 Jun; 74(300):147-54. PubMed ID: 8396196
    [Abstract] [Full Text] [Related]

  • 31. In vitro activity of CP-74,667. A new fluoroquinolone compared with other quinolones.
    Gu JW, Fang W, Chin NX, Neu HC.
    Diagn Microbiol Infect Dis; 1992 Jun; 15(7):613-20. PubMed ID: 1330421
    [Abstract] [Full Text] [Related]

  • 32. [Comparative in vitro activity of garenoxacin (BMS-284756). Sentry program, Spain (1999-2000)].
    Loza E, Cantón R, Pascual A, Tubau F, Morosini MI, Almaraz F, Perea E, Martín R, Jones RN, Baquero F.
    Enferm Infecc Microbiol Clin; 2003 Oct; 21(8):404-9. PubMed ID: 14525705
    [Abstract] [Full Text] [Related]

  • 33. In vitro activity of Bay y 3118, a new quinolone.
    Fass RJ.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2348-57. PubMed ID: 8285618
    [Abstract] [Full Text] [Related]

  • 34. In vitro activity of HSR-903, a new quinolone.
    Takahashi Y, Masuda N, Otsuki M, Miki M, Nishino T.
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1326-30. PubMed ID: 9174193
    [Abstract] [Full Text] [Related]

  • 35. In vitro and in vivo evaluations of A-80556, a new fluoroquinolone.
    Clement JJ, Tanaka SK, Alder J, Vojtko C, Beyer J, Hensey D, Ramer N, McDaniel D, Chu DT.
    Antimicrob Agents Chemother; 1994 May; 38(5):1071-8. PubMed ID: 8067740
    [Abstract] [Full Text] [Related]

  • 36. In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial.
    Gootz TD, Brighty KE, Anderson MR, Schmieder BJ, Haskell SL, Sutcliffe JA, Castaldi MJ, McGuirk PR.
    Diagn Microbiol Infect Dis; 1994 Aug; 19(4):235-43. PubMed ID: 7851087
    [Abstract] [Full Text] [Related]

  • 37. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
    King A, Bethune L, Phillips I.
    J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
    [Abstract] [Full Text] [Related]

  • 38. In-vitro activity of PD 131628, a new quinolone antimicrobial agent.
    Cooper MA, Andrews JM, Wise R.
    J Antimicrob Chemother; 1992 May; 29(5):519-27. PubMed ID: 1320603
    [Abstract] [Full Text] [Related]

  • 39. In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.
    Bongaerts GP, Hoogkamp-Korstanje JA.
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2017-9. PubMed ID: 8239624
    [Abstract] [Full Text] [Related]

  • 40. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
    Matsuzaki K, Koyama H, Chiba A, Omika K, Harada S, Sato Y, Hasegawa M, Kobayashi I, Kaneko A, Sasaki J.
    Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.